jrnls.org logo
Submit

BROWSE ALL JOURNALS

SEE ALL 19 JOURNALS
Indian Journal of Pharmaceutical Education and ResearchNOW IN
Article

N-(2-(1H-benzo[d]imidazol-2-yl)Phenyl)-2- (Substituted-styryl)Aniline as Anti-proliferative Agents: Rejuvenating the Importance of Low Molecular Weight Ligands in Oncotherapeutics

Santosh Subhash Chhajed1★, Pramodkumar P Gupta2, Sanjay Kshirsagar1, Sakshi Tomar1, Debarshi Kar Mahapatra3, Raji Sundararajan4★ Corresponding author

  1. 1Department of Pharmaceutical Chemistry, Institute of Pharmacy, MET’s Bhujbal Knowledge City, Nashik, Maharashtra, INDIA.
  2. 2School of Biotechnology and Bioinformatics, D.Y. Patil University, Navi Mumbai, Maharashtra, INDIA.
  3. 3Department of Pharmaceutical Chemistry, Dadasaheb Balpande College of Pharmacy, Nagpur, Maharashtra, INDIA.
  4. 4School of Engineering Technology, Purdue University, West Lafayette, Indiana, USA.

CORRESPONDENCE

Santosh Subhash Chhajed

Department of Pharmaceutical Chemistry, Institute of Pharmacy, MET’s Bhujbal Knowledge City, Nashik, Maharashtra, INDIA.

santosh_chhajed@rediffmail.com

Received: 12-07-2019; Revised: 31-12-2019; Accepted: 30-01-2020.

Volume 54, Issue 2 · pp. 432–439 · PUBLISHED 2020 · DOI: 10.5530/ijper.54.2.49

View on IJPER original site ↗

ABSTRACT

Background: The rationale behind the study involved that in individuality benzimidazolebased molecules demonstrates significant anti-proliferative activity; chalcone molecules like xanthohumol are known to express noteworthy anti-cancer activity; benzamide derived products show remarkable inhibition of HDAC (an emerging anti-proliferative target) and styrene-based compounds possesses notable anti-tumor activity. Materials and Methods: In this research, an attempt was made to synthesize and characterize a series of hybridized molecules of the prototype (E)-N-(2-(1H-benzo[d]imidazol-2-yl) phenyl)-2-(substituted-styryl)aniline which comprises of a benzimidazole function; along with a chalcone (or styryl) moiety linked by a benzamide. The study involved screening of the novel derivatives against non-small cell lung cancer cell line (H460; ATCC: HTB177) and human colorectal cancer cell line (HCT116; ATCC: CCL-247) using Propidium Iodide assay. In silico docking study was also performed against protein tyrosine kinase (PDB ID: 2J5F) to determine the probable mechanism of action of the novel compounds. Results: The study reflected the profound role and positions of substitution on the phenyl moiety of the benzimidazole system. The compound DSTYR4 displayed most potent antiproliferative activity with IC50 values of 2.98 μM against HCT116 cell line and 5.15 μM against H460 cell line. Conclusion: The research fruitfully rejuvenates the potentials and importance of small molecular weight ligands for experimental oncology.

KEYWORDS

Open in new tab

REFERENCES

As published

Showing references and in-text citations exactly as published.

    Cite this article

    SELECT FORMAT

    Chhajed, S. S., Gupta, P. P., Kshirsagar, S., Tomar, S., Mahapatra, D. K., & Sundararajan, R. (2020). N-(2-(1H-benzo[d]imidazol-2-yl)Phenyl)-2- (Substituted-styryl)Aniline as Anti-proliferative Agents: Rejuvenating the Importance of Low Molecular Weight Ligands in Oncotherapeutics. Indian Journal of Pharmaceutical Education and Research, 54(2), 432–439. https://doi.org/10.5530/ijper.54.2.49